Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUALIVA study of earlier ivabradine introduction in systolic heart failure
2014-003286-21Phase 2Terminated
- Sponsor
- University College Dublin
- Start
- Nov 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ivabradine, bisoprolol and carvedilol in heart failure with reduced ejection fraction (HFrEF) (2 arms), sponsored by University College Dublin. Primary endpoint: Change in 6-minute walk test distance. Started Nov 2014; status: terminated.
02
Drugs
ivabradinebisoprololcarvedilol
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on 2014-003286-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003286-21.